AC Immune (ACIU) Payables (2015 - 2026)
AC Immune (ACIU) posted quarterly Payables of $1.7 billion for Q1 2026, up 63236.65% year-over-year from N/an in Q1 2025, and down 34.9% quarter-over-quarter from $2.6 billion in Q4 2025.
AC Immune (ACIU) Payables (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Payables for 12 consecutive years, with $1.7 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 63236.65% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (up 63236.65% YoY), while the FY2025 annual figure was $2.5 billion, up 82106.26% from the prior year.
- Payables fell to $1.7 billion in Q1 2026 per ACIU's latest filing, from $2.6 billion in the prior quarter.
- Across five years, Payables topped out at $2.6 billion in Q4 2025 and bottomed at $964322.4 in Q4 2022.
- Historically, Payables has averaged $416.6 million across 5 years, with a median of $2.7 million in 2025.
- Annual changes were most pronounced in 2022 — Payables sank 99.96% — and 2023, when it soared 196185.83%.
- AC Immune's Payables stood at $964322.4 in 2022, then surged by 196185.83% to $1.9 billion in 2023, then slumped by 99.84% to $3.0 million in 2024, then jumped by 85176.15% to $2.6 billion in 2025, then sank by 34.9% to $1.7 billion in 2026.
- Business Quant data shows ACIU's Payables at $1.7 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Mn |
| Mar 31, 2026 | 1.68 Bn |
| Dec 31, 2025 | 2.59 Bn |
| Sep 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 1.89 Bn |
| Sep 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 964,322.36 |
| Sep 30, 2022 | 1.57 Mn |
| Jun 30, 2022 | 349.90 Mn |
| Mar 31, 2022 | 542.49 Mn |
| Dec 31, 2021 | 2.17 Bn |
| Sep 30, 2021 | 234.16 Mn |